UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis

PLoS neglected tropical diseases, 2008-05, Vol.2 (5), p.e236

2008

Volltextzugriff (PDF)

Efficacy and Safety of Azithromycin vs Levofloxacin in the Outpatient Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

Chest, 2003-03, Vol.123 (3), p.772-777

2003

Volltextzugriff (PDF)

Lack of Bioequivalence When Levofloxacin and Calcium-Fortified Orange Juice Are Coadministered to Healthy Volunteers

Journal of clinical pharmacology, 2003-05, Vol.43 (5), p.539-544

2003

Volltextzugriff (PDF)

Pharmacokinetics in Serum and Leukocyte Exposures of Oral Azithromycin, 1,500 Milligrams, Given over a 3- or 5-Day Period in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 1999-01, Vol.43 (1), p.163-165

1999

Volltextzugriff (PDF)

Treatment of Legionnaires' disease

Drugs (New York, N.Y.), 2005-01, Vol.65 (5), p.605-614

AMSDEN, Guy W

2005

Volltextzugriff (PDF)

Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

Journal of antimicrobial chemotherapy, 2005-01, Vol.55 (1), p.10-21

AMSDEN, G. W

2005

Volltextzugriff (PDF)

Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers

The American journal of tropical medicine and hygiene, 2007-06, Vol.76 (6), p.1153

2007

Volltextzugriff (PDF)

Effect of Grapefruit Juice on Clarithromycin Pharmacokinetics

Antimicrobial Agents and Chemotherapy, 1998-04, Vol.42 (4), p.927-929

1998

Volltextzugriff (PDF)

Pneumococcal resistance in perspective: how well are we combating it?

The Pediatric infectious disease journal, 2004-02, Vol.23 (2 Suppl), p.S125-S128

AMSDEN, GUY W

2004

Volltextzugriff (PDF)

Effect of Terbinafine on Theophylline Pharmacokinetics in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 1998-03, Vol.42 (3), p.695-697

1998

Volltextzugriff (PDF)

Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis

International journal of antimicrobial agents, 2007-01, Vol.29 (1), p.56-61

2007

Volltextzugriff (PDF)

We should not always be eager to replace old toys with new ones

Current infectious disease reports, 2008, Vol.10 (1), p.7-8

Amsden, Guy W.

2008

Volltextzugriff (PDF)

Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate

Journal of cystic fibrosis, 2006-08, Vol.5 (3), p.153-157

2006

Volltextzugriff (PDF)

Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers

Journal of antimicrobial chemotherapy, 2001-01, Vol.47 (1), p.61-66

2001

Volltextzugriff (PDF)

The association of erythromycin and infantile hypertrophic pyloric stenosis: Causal or coincidental?

Drug safety, 2002, Vol.25 (13), p.929-942

2002

Volltextzugriff (PDF)

Lack of Effect of Zafirlukast on the Pharmacokinetics of Azithromycin, Clarithromycin, and 14-Hydroxyclarithromycin in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1152-1155

1999

Volltextzugriff (PDF)

A Randomized, Crossover Design Study of the Pharmacology of Extended-Spectrum Fluoroquinolones for Pneumococcal Infections

Chest, 1999-07, Vol.116 (1), p.115-119

1999

Volltextzugriff (PDF)

Macrolide drug interactions: an update

The Annals of pharmacotherapy, 2000-04, Vol.34 (4), p.495

2000

Volltextzugriff (PDF)

Are we on the road to eliminating pneumococcal infections

Current infectious disease reports, 2007-01, Vol.9 (1), p.5-6

Amsden, Guy W

2007

Volltextzugriff (PDF)

Regulatory disincentives for developing antibiotics for common indications

Current infectious disease reports, 2007-01, Vol.9 (1), p.29-34

Amsden, Guy W

2007

Volltextzugriff (PDF)

Oral Cimetidine Prolongs Clarithromycin Absorption

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1578-1580

1998

Volltextzugriff (PDF)

Telithromycin: the first of the ketolides

The Annals of pharmacotherapy, 2002-03, Vol.36 (3), p.452

2002

Volltextzugriff (PDF)

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

Treatments in respiratory medicine, 2005, Vol.4 (2), p.117-122

2005

Volltextzugriff (PDF)

Industry sponsorship in research and publishing: who is really to blame for perceived bias?

The Annals of pharmacotherapy, 2004-04, Vol.38 (4), p.714

Amsden, Guy W

2004

Volltextzugriff (PDF)

Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis

The Annals of pharmacotherapy, 2005-10, Vol.39 (10), p.1678

2005

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(78)
Berichte
(2)

Sprache

Englisch
(80)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Humans
(59)
Pharmacology & Pharmacy
(55)
Biological And Medical Sciences
(43)
Medical Sciences
(43)
Pharmacology. Drug Treatments
(41)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(35)
Antibacterial Agents
(30)
Male
(30)
Adult
(29)
Female
(29)
Cross-Over Studies
(16)
Drug Interactions
(16)
Infectious Diseases
(16)
Anti-Bacterial Agents - Pharmacokinetics
(15)
Anti-Bacterial Agents - Therapeutic Use
(15)
Microbiology
(13)
Middle Aged
(12)
Anti-Bacterial Agents - Administration & Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis

Efficacy and Safety of Azithromycin vs Levofloxacin in the Outpatient Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

Lack of Bioequivalence When Levofloxacin and Calcium-Fortified Orange Juice Are Coadministered to Healthy Volunteers

Pharmacokinetics in Serum and Leukocyte Exposures of Oral Azithromycin, 1,500 Milligrams, Given over a 3- or 5-Day Period in Healthy Subjects

Treatment of Legionnaires' disease

Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers

Effect of Grapefruit Juice on Clarithromycin Pharmacokinetics

Pneumococcal resistance in perspective: how well are we combating it?

Effect of Terbinafine on Theophylline Pharmacokinetics in Healthy Volunteers

Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis

We should not always be eager to replace old toys with new ones

Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate

Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers

The association of erythromycin and infantile hypertrophic pyloric stenosis: Causal or coincidental?

Lack of Effect of Zafirlukast on the Pharmacokinetics of Azithromycin, Clarithromycin, and 14-Hydroxyclarithromycin in Healthy Volunteers

A Randomized, Crossover Design Study of the Pharmacology of Extended-Spectrum Fluoroquinolones for Pneumococcal Infections

Macrolide drug interactions: an update

Are we on the road to eliminating pneumococcal infections

Regulatory disincentives for developing antibiotics for common indications

Oral Cimetidine Prolongs Clarithromycin Absorption

Telithromycin: the first of the ketolides

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

Industry sponsorship in research and publishing: who is really to blame for perceived bias?

Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis

Suchergebnisse filtern